CF
TMO icon

Copperwynd Financial’s Thermo Fisher Scientific TMO Stock Holding History

Copperwynd Financial’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$1.63M Buy
4,031
+601
+18% +$251K 0.41% 44
2025
Q1 		$1.71M Buy
3,430
+1,020
+42% +$552K 0.47% 39
2024
Q4 		$1.25M Sell
2,410
-737
-23% -$405K 0.35% 51
2024
Q3 		$1.95M Buy
3,147
+187
+6% +$111K 0.59% 31
2024
Q2 		$1.82M Buy
2,960
+356
+14% +$204K 0.59% 30
2024
Q1 		$1.51M Buy
2,604
+191
+8% +$107K 0.54% 34
2023
Q4 		$1.28M Buy
2,413
+135
+6% +$65.3K 0.51% 36
2023
Q3 		$1.15M Buy
2,278
+29
+1% +$15.5K 0.54% 32
2023
Q2 		$1.17M Buy
2,249
+49
+2% +$26.4K 0.55% 40
2023
Q1 		$1.27M Buy
2,200
+787
+56% +$444K 0.65% 37
2022
Q4 		$778K Sell
1,413
-48
-3% -$25.4K 0.44% 52
2022
Q3 		$741K Sell
1,461
-90
-6% -$50.4K 0.43% 46
2022
Q2 		$842K Sell
1,551
-31
-2% -$17.1K 0.5% 43
2022
Q1 		$934K Buy
1,582
+39
+3% +$22.4K 0.39% 42
2021
Q4 		$1.03M Sell
1,543
-34
-2% -$21.2K 0.39% 36
2021
Q3 		$901K Sell
1,577
-17
-1% -$9.33K 0.37% 43
2021
Q2 		$804K Buy
1,594
+31
+2% +$14.6K 0.34% 43
2021
Q1 		$713K Sell
1,563
-118
-7% -$56.3K 0.32% 40
2020
Q4 		$783K Sell
1,681
-98
-6% -$46K 0.38% 40
2020
Q3 		$785K Sell
1,779
-77
-4% -$31.8K 0.42% 35
2020
Q2 		$672K Sell
1,856
-194
-9% -$65K 0.38% 34
2020
Q1 		$581K Sell
2,050
-245
-11% -$77.3K 0.28% 22
2019
Q4 		$745K Buy
2,295
+36
+2% +$10.9K 0.39% 41
2019
Q3 		$663K Buy
2,259
+122
+6% +$34.9K 0.38% 40
2019
Q2 		$627K Sell
2,137
-27
-1% -$7.44K 0.36% 37
2019
Q1 		$592K Buy
2,164
+14
+0.7% +$3.48K 0.35% 40
2018
Q4 		$481K Sell
2,150
-89
-4% -$20.9K 0.3% 33
2018
Q3 		$546K Buy
2,239
+33
+1% +$7.59K 0.33% 45
2018
Q2 		$457K Buy
2,206
+13
+0.6% +$2.76K 0.32% 42
2018
Q1 		$453K Buy
2,193
+137
+7% +$28.8K 0.31% 44
2017
Q4 		$390K Buy
+2,056
New +$394K 0.28% 57

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Copperwynd Financial's TMO Position: Q2 2025 in Review

Copperwynd Financial increased its Thermo Fisher Scientific (TMO) stake by 18% in Q2 2025, buying an estimated $251K and bringing the position to 4,031 shares worth $1.63M. The position accounts for 0.41% of the portfolio, ranked #44.

Copperwynd Financial first reported a position in TMO in Q4 2017 and has held it in 31 quarters since. The position peaked at $1.95M in Q3 2024. 2,454 funds tracked by Wall St. Rank hold TMO as of Q2 2025.

  • Copperwynd Financial held 4,031 shares of Thermo Fisher Scientific worth $1.63M as of Q2 2025.
  • Copperwynd Financial bought 601 Thermo Fisher Scientific shares in Q2 2025, an estimated $251K.
  • Thermo Fisher Scientific made up 0.41% of Copperwynd Financial's portfolio in Q2 2025, its #44 holding.
  • Copperwynd Financial first reported a position in Thermo Fisher Scientific in Q4 2017 and has held it in 31 quarters since.
  • Copperwynd Financial's Thermo Fisher Scientific position peaked at $1.95M in Q3 2024.
  • 2,454 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2025.

Based on Copperwynd Financial's 13F filing for Q2 2025, filed 24 Jul 2025.